Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Risk Prediction to Identify Patients at Risk for Chronic Kidney Disease (Short Name: RISK [Risk InterventionS for Chronic Kidney Disease])

NCT07857200 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT07857200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07857200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Risk Prediction to Identify Patients at Risk for Chronic Kidney Disease (Short Name: RISK [Risk InterventionS for Chronic Kidney Disease])
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Recruiting
Start date
August 20, 2026
Completion date
December 31, 2027
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ckd - chronic kidney disease